<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.2043  Pyrantel pamoate suspension.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. (1) Each milliliter (mL) contains pyrantel pamoate equivalent to 50 milligrams (mg) pyrantel base.</p><p class="depth2"><em>(1)</em> Each milliliter (mL) contains pyrantel pamoate equivalent to 50 milligrams (mg) pyrantel base.</p><p class="depth2"><em>(2)</em> Each mL contains pyrantel pamoate equivalent to 2.27 or 4.54 mg pyrantel base.</p><p class="depth2"><em>(3)</em> Each mL contains pyrantel pamoate equivalent to 4.54 mg pyrantel base.</p><p class="depth1"><em>(b)</em> Sponsors. See sponsors in Sec. 510.600(c) of this chapter for uses as in paragraph (d) of this section.</p><p class="depth2"><em>(1)</em> Nos. 000859, 054771, and 058829 for use of the product described in paragraph (a)(1) as in paragraph (d)(1) of this section.</p><p class="depth2"><em>(2)</em> Nos. 054771, 055246, 058829, and 059130 for use of the products described in paragraph (a)(2) as in paragraph (d)(2) of this section.</p><p class="depth2"><em>(3)</em> No. 023851 for use of the product described in paragraph (a)(3) as in paragraph (d)(2) of this section.</p><p class="depth1"><em>(c)</em> Special considerations. See Sec. 500.25 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions of use--(1) Horses and ponies. It is used as follows:</p><p class="depth2"><em>(1)</em> Horses and ponies. It is used as follows:</p><p class="depth3"><em>(i)</em> Amount. 3 mg per pound (/lb) body weight as a single dose mixed with the usual grain ration, or by stomach tube or dose syringe.</p><p class="depth3"><em>(ii)</em> Indications for use. For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum); and small strongyles.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses intended for human consumption. When the drug is for administration by stomach tube, it shall be labeled: ``Federal law restricts this drug to use by or on the order of a licensed veterinarian.''</p><p class="depth2"><em>(2)</em> Dogs. It is used as follows:</p><p class="depth3"><em>(i)</em> Dogs and puppies--(A) Amount. 2.27 mg/lb body weight as a single dose in the animal's feed bowl by itself or mixed in a small quantity of food.</p><p class="depth4"><em>(A)</em> Amount. 2.27 mg/lb body weight as a single dose in the animal's feed bowl by itself or mixed in a small quantity of food.</p><p class="depth4"><em>(B)</em> Indications for use. For the removal of large roundworms (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala).</p><p class="depth4"><em>(C)</em> Limitations. Additional treatment may be required and should be confirmed by fecal examination within 2 to 4 weeks.</p><p class="depth3"><em>(ii)</em> Dogs, puppies, and lactating bitches after whelping--(A) Amount. 2.27 mg/lb body weight.</p><p class="depth4"><em>(A)</em> Amount. 2.27 mg/lb body weight.</p><p class="depth4"><em>(B)</em> Indications for use. To prevent reinfections of T. canis.</p><p class="depth4"><em>(C)</em> Limitations. Administer to puppies at 2, 3, 4, 6, 8, and 10 weeks of age. Administer to lactating bitches 2 to 3 weeks after whelping. Adult dogs kept in heavily contaminated quarters may be treated at monthly intervals.
[67 FR 43248, June 27, 2002, as amended at 68 FR 54803, Sept. 19, 2003; 68 FR 55199, Sept. 23, 2003; 68 FR 55825, Sept. 29, 2003; 75 FR 52622, Aug. 27, 2010; 76 FR 17337, Mar. 29, 2011; 78 FR 17596, Mar. 22, 2013; 79 FR 28827, May 20, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§.
          Code available <a href="https://github.com/anthonygarvan/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5
      </div>
    </div>
  </footer>
  </body>
</html>
